Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sid, I don't know if you actually keep up with the company updates or not, but he has been executing according to the plan he outlined back in November 2017. Ya'll shouldn't even be able to crack a smile until this fall smh, but I'm sure that won't stop you lol
Keep us posted on L2 though, I'd love it if JP could overcome his greed for 02s and get back in. Anything to quiet the peanut gallery.
I'm patient. I am supporting an entrepreneur in his experiment in hopes to benefit those in need. If it was all about lining my pockets, I'd pick less risky investments.
time's always running out... we have time. None of you thought the company would even be around right now. You were wrong.
why don't you get me a cup of coffee. caffe latte. twist of lemon. sweet n lo.
onion bagel. cream cheese.
72 million free trading shares = #fakenews
intention to dump = #hehasnoideafolks #hasntdumpedyet #whywouldhe?
waiting for .02s = #maybemaybenot, doesn't matter this security is essentially an option with an expiration end of year (unless new info emerges), buying at .02 or .03 who cares it's either 0 or $$$
6:52 am saturday morning. you wouldn't want anyone considering AMBS to no see a negative post on Saturday morning, lest they lose their shirt. Thanks for holding us accountable Japers
you're a hero Japers!
or how about this? after lympo 2.0 is reintroduced at AAIC this week, will AMBS be able to obtain funding from Bill Gates new $30M initiative to jump start quick earlier stage alzheimers biomarkers?
got any news that isn't a year old?
got any posts that aren't so stale?
let me give you something new to shoot down:
Will AC Immune spend any of its newly raised approx $130M to let its current employee and former Eltoprazine/AMBS/psychogenics principal Dr. Lowe take over clinical development for PD-LID?
Why or why not? Is it a maybe?
pretty stupid take. if we don't get price appreciation in the next 6 months it's never gonna happen
somewhere around a couple hundred thousand i think
what do you mean we haven't been right? ya'll said they'd be bankrupt and the toxics would own all the assets and auction them off to the highest bidder... still waiting
sounds good man, go to sleep we'll see you in a few months
hardly a detail, it's the crux of the issue, but you're 99.9% sure it can't be done. I'm not so sure.
How high can it go? We could easily be a $1 pps in a snap, but you can see the history here. Plenty of naysayers on this board, but there's no pattern, they're all butt hurt about a single point of failure in 2015 that you need to evaluate yourself.
If everything went well, in 5 years your money could be on the order of $10+ pps. In 2 years, $5 pps is possible.
The company has no money, and 4 valuable subsidiaries.
As is, in my opinion, the diagnostic oughta be worth $25M, Elto $125M, MANF $50M, and Cutanogen $35M. That's about $1 a share.
If the diagnostic proves out as a valuable Alzheimer's biomarker, the market will anticipate trial adoption and revenues on the order of $10M which with a P/E makes that unit worth more like $100M+ especially given it's potential growth into diagnosis in the general public. This is potentially <12 months away.
If Elto can get started and have successful 2b data in PD-LID, it will be valued closer to $500M. That's 18 months away.
If Cutanogen can get some non-dilutive financing, it could be valued as if it's on the market very quickly, <12 months value the unit closer to $150M
If MANF can get funding to start a trial OR if Herantis Pharma generates successful results in what would be a near identical trial to what we would do, the market will 10x MANF's value over night to $500M. Herantis's trial is near half way through, and we'll have results in less than 12 months, with every month it continues solidifying market confidence in our unit. This is a symbiotic trial, not a zero sum competition trial.
So as you can see, whether we get funding or not, but especially if we can get the ball rolling as the company plans, within 12-18 months this is a $1.25B market cap company, not a $210M company that it could be any day week or month now. That potential $5 a share price in 12-18 months will have to be accounted for if financing becomes available via grants, deals, or revenues. Because of Herantis trial, it's not all about financing, but it's mostly all about the money at this point. By the end of the year if something isn't coming together, a tsunami of dilution is likely to wipe you out, and that is what is introducing the price capping risk in the market.
has nothing to do with that. Biotech analysts very split on the new aducanumab data.
has everything to do with sleepy market finding out about first study to propose a MANF mechanism and demonstrate effectiveness in a-syn PD model from a top 10 medical university in China.
https://sci-hub.tw/https://doi.org/10.1016/j.expneurol.2018.06.016
I know, I know Japers. We're gonna specialize in selling worm farms and call it, "I got Worms"
has nothing to do with that. Biotech analysts very split on the new aducanumab data.
has everything to do with sleepy market finding out about first study to propose a MANF mechanism and demonstrate effectiveness in a-syn PD model from a top 10 medical university in China.
I know, I know Japers. We're gonna specialize in selling worm farms and call it, "I got Worms"
I'm sure japers has all the blogs printed out hanging in his windowless little office of horrors, yarn running everywhere
nah man, don't know if you've heard or not, but we've got a 6 month window left before we're talking about RS. Don't even bring up that nonsense right now, I guaranty if it happens at all it won't be til next year. but you might get caught with your pants down here in the next 6 months.
sigh....
It's as if the entire website, including blogs from many many other companies and CEOS hadn't been taken down....
posts like that are sad
it'll pass through, ya
Siri, is 660,000 < 1,000,000
Hey siri, what's 33 million x .02?
You can double space your post and say a lot, but you're talking about one fateful decision 3 years ago. The only fact, not speculation, is the leadership made one terrible mistake 3 years ago.
serial liar, sociopath, thief- at least half of all great entrepreneurs have been called that at some point. It's a matter of perspective and character and time.
prediction is ladenburg
man, i was really rootin for you JP. maybe tomorrow. maybe the next day. maybe.
Just when I thought I was out! They pulled me back in....
No he didn't. Not that I think this is worth arguing about.
I bet JP is glad the US didn't make the world cup, because he spent years cheering for them and they never won.
net present value emphasis on "present"
haven't you seen a valuation done on a pharmaceutical compound before? basics....
that valuation is only if it works
^fake news or evidence of incompetence, either way, it's too late for the thing I fear, his heart is black and brain turned to mush
o/s was 205 on june 1
o/s was 205-ish on june 12
leak is at drip stage
spooky stuff
I vote every day I hold, or boy, or sell. And its 205 not 250...yet.
Math adds up.
man, someone just feasting abouts the 0.045 for weeks now
+80? please elaborate, because I thought it was infinite as a starting point. Does the stock price affect that at all? Like could I say overhang is 1M+ as an equally accurate statement?
Why only an update on elto? Why no update on cutanogen? Is it because things are less up in the air?
Couldn't find, and didn't select are two different things and you have no way of bridging the information gap to post facts about one or the other.
Halted means something very specific in biotech, and that is not what happened to elto.
Tsk tsk J have u no shame? Can't even explain?